Optune System + PEMBROLIZUMAB + Temozolomide

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Optune System + PEMBROLIZUMAB + Temozolomide
Treatment and conditionWhere it standsTrials
Optune System + PEMBROLIZUMAB + Temozolomide for glioblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1